Intradermally administered yellow fever vaccine at reduced doses induces a protective immune response: a randomized controlled non-inferiority trial
From PLoS ONE, published online Apr 23
|
Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia
From PLoS Pathog, published online Apr 18
|
Basolateral entry and release of New and Old World arenaviruses from human airway epithelia
From J Virol, published online Apr 16
|
Immune response during adverse events after 17D-derived yellow fever vaccination in Europe
From J Infect Dis, published online Apr 15
|
Quality assessment of nonanthrax vaccination data in the Defense Medical Surveillance System, 1998-2004
|
Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections
From Mar Clin Vaccine Immunol
|
Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions
From Antiviral Res, published online Feb 26
|
Global trends in emerging infectious diseases
|
Substitution of wild-type yellow fever asibi sequences for 17D vaccine sequences in ChimeriVax-Dengue 4 does not enhance infection of Aedes aegypti mosquitoes
From J Infect Dis, published online Feb 11
|
Pathogenic flaviviruses
|
Universal primers that amplify RNA from all three flavivirus subgroups
From Virol J, published online Jan 24
|
Concurrent infections by all four dengue virus serotypes during an outbreak of 2006 in Delhi, India
|
Dengue and hemorrhagic fever: a potential threat to public health in the United States
|
New World clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1
|
Ebola outbreak in Uganda "atypical," say experts
|
Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus
From Dec 12 PLoS Negl Trop Dis
|
Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality
From Int J Infect Dis, published online Dec 6
|
Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease
|
Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine
|
Studies of reservoir hosts for Marburg virus
From Emerg Infect Dis, published online Oct 23
|
Application of modified shell vial culture procedure for arbovirus detection
From PLoS ONE, published online Oct 17
|
Viral load as predictor of Crimean-Congo hemorrhagic fever outcome
From Emerg Infect Dis, published online Oct 12
|
Characterization of hemorrhagic fever with renal syndrome caused by hantaviruses, Estonia
From Emerg Infect Dis, published online Oct 12
|
Scientists say Ebola has pushed Western gorillas to the brink
|
Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever
From Sep Clin Vaccine Immunol
|
Dengue fever seroprevalence and risk factors, Texas-Mexico border, 2004
From Emerg Infect Dis, published online Aug 24
|
Marburg virus infection detected in a common African bat
From PLoS ONE, published online Aug 22
|
Implications of wildlife trade on the movement of avian influenza and other infectious diseases
From Jul Suppl J Wildl Dis
|
Dengue hemorrhagic fever--U.S.-Mexico border, 2005
|
Early blood profiles of virus infection in a monkey model for Lassa fever
|
Developing a research agenda and a comprehensive national prevention and response plan for Rift Valley fever in the United States
From Emerg Infect Dis, published online Jul 10
|
Pathogenic hantaviruses, northeastern Argentina and Paraguay
From Emerg Infect Dis, published online Jul 10
|
Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients
From Emerg Infect Dis, published online Jun 1
|
Rift Valley fever outbreak with east-central African virus lineage in Mauritania, 2003
From Emerg Infect Dis, published online Jun 1
|
Successful topical respiratory tract immunization of primates against Ebola virus
|
| Viral Hemorrhagic Fever (VHF): Current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis
CIDRAP-authored overview, updated March 1 with new research
|
A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity
|
Age and clinical dengue illness
From Emerg Infect Dis, published online Apr 26
|
Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease
|
Dengue virus evolution and virulence models
From Clin Infect Dis, published online Apr 18
|
Viral load and Crimean-Congo hemorrhagic fever (letter)
From Emerg Infect Dis, published online Apr 18
|
Infection control for viral haemorrhagic fevers in the African health care setting
|
